Latin America Non Invasive Prenatal Testing Market Size & Outlook

The non invasive prenatal testing market in Latin America is expected to reach a projected revenue of US$ 366.9 million by 2030. A compound annual growth rate of 10.1% is expected of Latin America non invasive prenatal testing market from 2023 to 2030.

Revenue, 2022 (US$M)
$170.4
Forecast, 2030 (US$M)
$366.9
CAGR, 2023 - 2030
10.1%
Report Coverage
Latin America

Latin America non invasive prenatal testing market, 2018-2030 (US$M)

Latin

Related Markets

Latin America non invasive prenatal testing market highlights

  • The Latin America non invasive prenatal testing market generated a revenue of USD 170.4 million in 2022.
  • The market is expected to grow at a CAGR of 10.1% from 2023 to 2030.
  • In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
  • 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.
  • Country-wise, Argentina is expected to register the highest CAGR from 2023 to 2030.


Latin America data book summary

Market revenue in 2022USD 170.4 million
Market revenue in 2030USD 366.9 million
Growth rate10.1% (CAGR from 2022 to 2030)
Largest segment13-24 weeks
Fastest growing segment0-12 weeks
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentation0-12 weeks, 13-24 weeks, 25-36 weeks
Key market players worldwideCooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics


Other key industry trends

  • In terms of revenue, Latin America region accounted for 4.5% of the global non invasive prenatal testing market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,631.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non Invasive Prenatal Testing Market Scope

Non invasive prenatal testing market segmentation & scope
0-12 weeks
13-24 weeks
25-36 weeks
High & Average Risk
Low Risk
Ultrasound Detection
Biochemical Screening Tests
Cell-Free DNA in Maternal Plasma Tests
NGS
Array Technology
PCR
Others
Consumables & Reagents
Instruments
Trisomy
Microdeletion Syndrome
Other Applications
Hospitals & Clinics
Diagnostic Laboratories

Non Invasive Prenatal Testing Market Companies

Name Profile # Employees HQ Website

Latin America non invasive prenatal testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.


13-24 weeks was the largest segment with a revenue share of 52.11% in 2022. Horizon Databook has segmented the Latin America non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.


Technological developments are expected to contribute to market expansion. Increasing government expenditure on R&D, presence of skilled healthcare professionals, rising focus of multinational pharmaceutical companies in the clinical diagnostics sector, and the increase in patient awareness levels are expected to drive the market growth over the forecast period. Rising incidence of chronic diseases coupled with growing geriatric population is also a factor driving the regional clinical diagnostic market. 


Furthermore, increasing healthcare spending in developing countries in this region and increasing medical tourism are responsible for market growth. The Human Genome & Stem Cell Research Center (HUG - CELL) is a notable body at the University of São Paulo, which researches human genome and sequence mapping of indigenous populations and crops of Brazil. Advance Medical and Medica Fertil for Ariosa Diagnosticas and Natera are respective distributors for Harmony and Panorama non-invasive prenatal tests, thereby propelling the growth of the Latin America non-invasive prenatal testing market.

Reasons to subscribe to Latin America non invasive prenatal testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America non invasive prenatal testing market databook

  • Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America non invasive prenatal testing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America non invasive prenatal testing market size, by country, 2018-2030 (US$M)

Latin America Non Invasive Prenatal Testing Market Outlook Share, 2022 & 2030 (US$M)

Latin America non invasive prenatal testing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more